<drug type="small molecule" created="2015-11-30" updated="2017-04-01">
  <drugbank-id primary="true">DB09499</drugbank-id>
  <name>Sodium thiosulfate</name>
  <description>Sodium thiosulfate has the chemical name thiosulfuric acid, disodium salt, pentahydrate. The chemical formula is Na2S2O3• 5H2O and the molecular weight is 248.17. Sodium Thiosulfate Injection is a cyanide antidote which contains one 50 mL glass vial containing a 25% solution of Sodium Thiosulfate Injection.&#13;
&#13;
It has been indicated as antidote for cyanide poisoning. It is also used as adjunct agent for patients taking cisplatin chemotherapy.  &#13;
Beside the above indications, sodium thiosulfate could be used as ingredient in the following: agricultural chemicals (non-pesticidal),  fillers, intermediates, laboratory chemicals, oxidizing/reducing agents, process regulators, processing aids, and solids separation agents.</description>
  <cas-number/>
  <unii>HX1032V43M</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <title>MSDS</title>
        <url>https://www.ch.ntu.edu.tw/~genchem99/msds/exp19/Na2S2O3.pdf</url>
      </link>
      <link>
        <title>Monograph</title>
        <url>https://www.drugs.com/mmx/sodium-thiosulfate.html</url>
      </link>
      <link>
        <title>product info</title>
        <url>https://www.drugs.com/pro/sodium-thiosulfate-injection.html</url>
      </link>
      <link>
        <title>product info</title>
        <url>https://pubchem.ncbi.nlm.nih.gov/compound/Sodium_thiosulphate#section=Use-and-Manufacturing</url>
      </link>
      <link>
        <title>database </title>
        <url>http://www.medsafe.govt.nz/profs/Datasheet/d/DBL-SodiumThiosulfateinj.pdf</url>
      </link>
    </links>
  </general-references>
  <synthesis-reference/>
  <indication>Antidote: Sodium thiosulfate is indicated to counteract or neutralize actions of poisons, e.g. cyanide poisoning. &#13;
Antineoplastic adjunct: </indication>
  <pharmacodynamics>In dogs, pretreatment with sodium thiosulfate to achieve a steady state level of 2 µmol/mL increased the rate of conversion of cyanide to thiocyanate over 30-fold.</pharmacodynamics>
  <mechanism-of-action>As antidote: Sodium thiosulfate acts as a sulfur donor for the endogenous sulfur transferase enzyme, rhodanese. It is used together with sodium nitrite for cyanide poisiong as antidote. Cyanide has a very high affinity for iron in the ferric state. It reacts with the trivalent (ferric) iron of mitochondrial cytochrome oxidase, thereby inhibiting cellular respiration, resulting in lactic acidosis and cytotoxic hypoxia. Sodium nitrite reacts with hemoglobin to form methemoglobin, which competes with cytochrome oxidase for the cyanide ion. Cyanide binds to methemoglobin to form cyanmethemoglobin and restore the activity of cytochrome oxidase. When cyanide dissociates from methemoglobin, sodium thiosulfate facilitates its conversion by rhodanese to thiocyanate, a less toxic ion. &#13;
As antineoplastic adjunct: The mechanism of action of sodium thiosulfate is still not clear, but it is thought that it forms a complex with cisplastin via covalent bond, which renders cisplastin more readily eliminated from the kidneys. It was believed also that sodium thiosulfate plays a role in the protection from nephrotoxicity caused by cisplastin, through reducing delivery of cisplatin to the kidneys and by neutralizing cisplatin in the kidneys where sodium thiosulfate is highly concentrated.  </mechanism-of-action>
  <toxicity>Oral, rat : LD50 = &gt;5000mg/kg</toxicity>
  <metabolism>Data not found.</metabolism>
  <absorption>Thiosulfate taken orally is not systemically absorbed. Most of the thiosulfate is oxidized to sulfate or is incorporated into endogenous sulphur compounds; a small proportion is excreted through the kidneys. &#13;
After an intravenous injection of 1 g sodium thiosulfate in patients, the reported serum thiosulfate half-life was approximately 20 minutes. However, after an intravenous injection of a substantially higher dose of sodium thiosulfate (150 mg/kg, that is, 9 g for 60 kg body weight) in normal healthy men, the reported elimination half-life was 182 minutes.</absorption>
  <half-life>Thiosulfate: 15 to 20 minutes.</half-life>
  <protein-binding>Data not found.</protein-binding>
  <route-of-elimination>Elimination is primarily renal, approximately 20-50% of exogenously administered thiosulfate is eliminated unchanged via the kidneys&#13;
Antidote (to cyanide poisoning): Primarily as thiocyanate.&#13;
Antineoplastic adjunct: As a nontoxic sodium thiosulfate/cisplatin complex. </route-of-elimination>
  <volume-of-distribution>150 mL/kg. </volume-of-distribution>
  <clearance>1.86 ± 0.45 ml/min per kg.&#13;
</clearance>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Adasept Acne Gel</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00326577</dpd-id>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nithiodote</name>
      <labeller>Hope Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>60267-812</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-01-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number>NDA201444</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Seacalphyx</name>
      <labeller>Seaford Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02386666</dpd-id>
      <started-marketing-on>2013-01-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sodium Polysulthionate and Folic Acid</name>
      <labeller>Solubiomix</labeller>
      <ndc-id/>
      <ndc-product-code>69499-904</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Polysulthionate, 5-methyltetrahydrofolate</name>
      <labeller>Solubiomix</labeller>
      <ndc-id/>
      <ndc-product-code>69499-921</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-07-21</started-marketing-on>
      <ended-marketing-on>2030-01-01</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Polysulthionate, 5-mthf</name>
      <labeller>Solubiomix</labeller>
      <ndc-id/>
      <ndc-product-code>69499-922</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-01-09</started-marketing-on>
      <ended-marketing-on>2016-01-15</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Thiosulfate</name>
      <labeller>Hope Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>60267-705</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-02-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>250 mg/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA203923</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Thiosulfate Inj 25% USP</name>
      <labeller>David Bull Laboratories (Pty) Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01908820</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>250 mg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sodium Thiosulfate Injection USP</name>
      <labeller>Hope Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02428393</dpd-id>
      <started-marketing-on>2015-11-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>250 mg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sodium Thiosulfate Injection USP 25%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02137186</dpd-id>
      <started-marketing-on>1998-07-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>25 %</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Xizflus</name>
      <labeller>Basiem</labeller>
      <ndc-id/>
      <ndc-product-code>69597-922</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-01-09</started-marketing-on>
      <ended-marketing-on>2016-01-15</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Xizflus</name>
      <labeller>Basiem</labeller>
      <ndc-id/>
      <ndc-product-code>69597-921</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-07-14</started-marketing-on>
      <ended-marketing-on>2030-01-01</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Sodium Thiosulfate</name>
      <ingredients>Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Nithiodote</name>
      <ingredients>Sodium Nitrite + Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Polysulthionate, 5-methyltetrahydrofolate</name>
      <ingredients>Sulfur + Sodium sulfate + Sodium thiosulfate + Levomefolic acid</ingredients>
    </mixture>
    <mixture>
      <name>Xizflus</name>
      <ingredients>Sulfur + Sodium sulfate + Sodium thiosulfate + Levomefolic acid</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Polysulthionate, 5-mthf</name>
      <ingredients>Sulfur + Sodium sulfate + Sodium thiosulfate + 5-methyltetrahydrofolic acid</ingredients>
    </mixture>
    <mixture>
      <name>Xizflus</name>
      <ingredients>Sulfur + Sodium sulfate + Sodium thiosulfate + 5-methyltetrahydrofolic acid</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Thiosulfate Injection USP 25%</name>
      <ingredients>Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Thiosulfate Inj 25% USP</name>
      <ingredients>Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Seacalphyx</name>
      <ingredients>Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Thiosulfate Injection USP</name>
      <ingredients>Sodium thiosulfate</ingredients>
    </mixture>
    <mixture>
      <name>Adasept Acne Gel</name>
      <ingredients>Triclosan + Sodium thiosulfate + Salicylic acid</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Polysulthionate and Folic Acid</name>
      <ingredients>Folic Acid + Sulfur + Sodium sulfate + Sodium thiosulfate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Anti-Bacterial Agents</category>
      <mesh-id>D000900</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antidotes</category>
      <mesh-id>D000931</mesh-id>
    </category>
    <category>
      <category>Antioxidants</category>
      <mesh-id>D000975</mesh-id>
    </category>
    <category>
      <category>Antitubercular Agents</category>
      <mesh-id>D000995</mesh-id>
    </category>
    <category>
      <category>Chelating Agents</category>
      <mesh-id>D002614</mesh-id>
    </category>
    <category>
      <category>Chemical Actions and Uses</category>
      <mesh-id>D020164</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Inorganic Chemicals</category>
      <mesh-id>D007287</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Molecular Mechanisms of Pharmacological Action</category>
      <mesh-id>D045504</mesh-id>
    </category>
    <category>
      <category>Organic Chemicals</category>
      <mesh-id>D009930</mesh-id>
    </category>
    <category>
      <category>Pharmacologic Actions</category>
      <mesh-id>D020228</mesh-id>
    </category>
    <category>
      <category>Physiological Effects of Drugs</category>
      <mesh-id>D045505</mesh-id>
    </category>
    <category>
      <category>Protective Agents</category>
      <mesh-id>D020011</mesh-id>
    </category>
    <category>
      <category>Sequestering Agents</category>
      <mesh-id>D064449</mesh-id>
    </category>
    <category>
      <category>Specialty Uses of Chemicals</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Sulfates</category>
      <mesh-id>D013431</mesh-id>
    </category>
    <category>
      <category>Sulfur Acids</category>
      <mesh-id>D013456</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Sulfuric Acids</category>
      <mesh-id>D013464</mesh-id>
    </category>
    <category>
      <category>Therapeutic Uses</category>
      <mesh-id>D045506</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>250 mg</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral; Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>250 mg/mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength>250 mg</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength>25 %</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents>
    <patent>
      <number>8496973</number>
      <country>United States</country>
      <approved>2011-03-29</approved>
      <expires>2031-03-29</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>8568793</number>
      <country>United States</country>
      <approved>2011-12-24</approved>
      <expires>2031-12-24</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB12768</drugbank-id>
      <name>BCG</name>
      <description>The therapeutic efficacy of Bcg can be decreased when used in combination with Sodium thiosulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09268</drugbank-id>
      <name>Picosulfuric acid</name>
      <description>The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Sodium thiosulfate.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>8910</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>74</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes>
    <enzyme position="1">
      <id>BE0004455</id>
      <name>Thiosulfate sulfurtransferase</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q16762" source="Swiss-Prot">
    <name>Thiosulfate sulfurtransferase</name>
    <general-function>Thiosulfate sulfurtransferase activity</general-function>
    <specific-function>Formation of iron-sulfur complexes, cyanide detoxification or modification of sulfur-containing enzymes. Other thiol compounds, besides cyanide, can act as sulfur ion acceptors. Also has weak mercaptopyruvate sulfurtransferase (MST) activity (By similarity). Together with MRPL18, acts as a mitochondrial import factor for the cytosolic 5S rRNA. Only the nascent unfolded cytoplasmic form is able to bind to the 5S rRNA.</specific-function>
    <gene-name>TST</gene-name>
    <locus/>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>33428.69</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:12388</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16762</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>THTR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.8.1.1</synonym>
      <synonym>Rhodanese</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0013119|Thiosulfate sulfurtransferase
MVHQVLYRALVSTKWLAESIRTGKLGPGLRVLDASWYSPGTREARKEYLERHVPGASFFD
IEECRDTASPYEMMLPSEAGFAEYVGRLGISNHTHVVVYDGEHLGSFYAPRVWWMFRVFG
HRTVSVLNGGFRNWLKEGHPVTSEPSRPEPAVFKATLDRSLLKTYEQVLENLESKRFQLV
DSRSQGRFLGTEPEPDAVGLDSGHIRGAVNMPFMDFLTEDGFEKGPEELRALFQTKKVDL
SQPLIATCRKGVTACHVALAAYLCGKPDVAVYDGSWSEWFRRAPPESRVSQGKSEKA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0013120|Thiosulfate sulfurtransferase (TST)
ATGGTTCATCAGGTGCTCTACCGGGCGCTGGTCTCCACCAAGTGGCTGGCGGAGTCCATC
AGGACTGGCAAGCTGGGGCCCGGCCTGCGGGTGCTGGACGCGTCCTGGTACTCACCAGGC
ACCCGAGAGGCCCGCAAGGAGTACCTCGAGCGCCACGTACCCGGCGCCTCTTTCTTTGAC
ATAGAAGAGTGCCGGGACACGGCGTCGCCCTACGAGATGATGCTGCCCAGCGAGGCTGGC
TTCGCCGAGTATGTGGGCCGCCTGGGCATCAGCAACCACACGCACGTGGTGGTGTATGAT
GGTGAACACCTGGGCAGCTTCTATGCTCCCCGGGTCTGGTGGATGTTCCGTGTGTTTGGC
CACCGCACCGTATCAGTGCTCAATGGTGGCTTCCGGAACTGGCTGAAGGAGGGCCACCCG
GTGACATCCGAGCCCTCACGCCCAGAACCGGCCGTCTTCAAAGCCACACTGGACCGCTCC
CTGCTCAAGACCTACGAGCAGGTGCTGGAGAACCTTGAATCTAAGAGGTTCCAGCTGGTG
GATTCAAGGTCTCAAGGGCGGTTCCTGGGCACCGAGCCGGAGCCGGATGCAGTAGGACTG
GACTCGGGCCATATCCGTGGTGCCGTCAACATGCCTTTCATGGACTTCCTGACTGAGGAT
GGCTTCGAGAAGGGCCCAGAAGAGCTCCGTGCTCTGTTCCAGACCAAGAAGGTGGATCTC
TCGCAGCCTCTCATTGCCACGTGCCGCAAGGGAGTCACCGCCTGCCACGTGGCCTTGGCT
GCCTACCTCTGCGGCAAGCCTGATGTGGCCGTGTACGATGGCTCCTGGTCCGAGTGGTTT
CGCCGGGCCCCCCCAGAGAGCCGTGTGTCCCAGGGAAAGTCTGAGAAGGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00581</identifier>
        <name>Rhodanese</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thiosulfate sulfurtransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>5S rRNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cyanate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rRNA import into mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rRNA transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfide oxidation, using sulfide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters/>
</drug>
